{"nctId":"NCT01537081","briefTitle":"Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections","startDateStruct":{"date":"2011-09"},"conditions":["Acute Upper Respiratory Tract Infection"],"count":2810,"armGroups":[{"label":"Mucinex 2400 mg/day","type":"EXPERIMENTAL","interventionNames":["Drug: Mucinex","Drug: Placebo"]},{"label":"Immediate-release Guaifenesin 800 mg/Day","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Immediate-release Guaifenesin","Drug: Placebo"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Mucinex","otherNames":["MucinexÂ®","guaifenesin"]},{"name":"Immediate-release Guaifenesin","otherNames":["IR guaifenesin","IR GGE"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1\\. Has developed cold symptoms within 3 days prior to dosing on Day 1.\n\nExclusion Criteria:\n\n1. Chronic illnesses.\n2. Febrile illness \\> 101 F within 7 days prior to Day 1,\n3. Pregnant.\n4. Known current malignancy.","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Summary Scores on the SUM8 Daily Cough and Phlegm Diary Card On the Morning of Day 4","description":"Participants completed diary cards twice a day that asked questions about their cough and phlegm status. The Daily Cough and Phlegm Diary Card consisted of eleven questions, eight core questions plus three questions that were answered dependent upon the response to core questions. The SUM8 consisted of the sum of the answers to the eight core questions. Each question was answered on a scale of 0-4, with 4 representing the greatest severity of symptoms. The SUM8 thus had a scale range of 0-32 with 0 representing best possible symptoms, and 32 representing greatest severity of symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.96","spread":"6.226"},{"groupId":"OG001","value":"12.87","spread":"6.078"},{"groupId":"OG002","value":"12.71","spread":"5.828"}]}]}]},{"type":"PRIMARY","title":"Summary Scores on the SUM8 Daily Cough and Phlegm Diary Card On the Morning of Day 5","description":"Participants completed diary cards twice a day that asked questions about their cough and phlegm status. The Daily Cough and Phlegm Diary Card consisted of eleven questions, eight core questions plus three questions that were answered dependent upon the response to core questions. The SUM8 consisted of the sum of the answers to the eight core questions. Each question was answered on a scale of 0-4, with 4 representing the greatest severity of symptoms. The SUM8 thus had a scale range of 0-32 with 0 representing best possible symptoms, and 32 representing greatest severity of symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.92","spread":"6.448"},{"groupId":"OG001","value":"10.80","spread":"6.261"},{"groupId":"OG002","value":"11.05","spread":"5.900"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":1122},"commonTop":["Headache","Diarrhoea","Nausea","Dizziness","Somnolence"]}}}